Showing results (391-400 of 544) with videos related to
Sort By:
Pageof 55
Vaccine: X|June 27, 2024
Comirnaty-induced cardiopulmonary distress and other symptoms of complement-mediated pseudo-anaphylaxis in a hyperimmune pig model: Causal role of anti-PEG antibodiesBálint András Barta, Tamás Radovits, Attila Balázs Dobos, et al.Vaccine: X|June 14, 2024
Vaccine delivery systems and administration routes: Advanced biotechnological techniques to improve the immunization efficacyAbdellatif Bouazzaoui, Ahmed A H AbdellatifVaccine: X|May 27, 2024
SARS-CoV-2 vaccination in Canadian blood donors: Insight into donor representativeness of the general populationSheila F O'Brien, Mindy Goldman, Behrouz Ehsani-Moghaddam, et al.Vaccine: X|December 16, 2025
Rhamnose polysaccharide-decorated outer membrane vesicles as a vaccine candidate targeting Group A Streptococcus from Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilisSowmya Ajay Castro, Sarah Thomson, Helen Alexandra Shaw, et al.Vaccine: X|May 6, 2024
Antibody responses to SARS-CoV-2 spike protein in a cohort of renal transplant recipients following two-dose primary immunization - A Caribbean country's perspectiveLesley Roberts, Carla-Maria Alexander, Michele Monteil, et al.Vaccine: X|April 24, 2024
Landscape review of active vaccine safety surveillance activities for COVID-19 vaccines globallyParisa A ShamaeiZadeh, Carmen Villamizar Jaimes, Maria Deloria Knoll, et al.Vaccine: X|December 21, 2023
Impact of herpes zoster and post-herpetic neuralgia on health-related quality of life in Miyun District of Beijing, China: An EQ-5D surveyDan Zhao, Luodan Suo, Li Lu, et al.Vaccine: X|November 15, 2021
Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT adjuvant induce broad, Th1 biased, humoral and cellular immune responses in miceChih-Yun Lai, Albert To, Teri Ann S Wong, et al.Vaccine: X|August 22, 2026
Mobile Vaccine Uptake (MoVeUP): a randomized effectiveness trial for a vaccine communication appEllen K Kerns, Songthip Ounpraseuth, Paul Darden, et al.Vaccine: X|August 14, 2026
Mincle receptor agonist UM-1098 and TLR4 agonist INI-2002 combination adjuvant enhances Th1 responses and provides protection against Mycobacterium tuberculosis challenge in miceViktoria Rungelrath, Grace Jones, Mushtaq Ahmed, et al.Pageof 55